Besirli Cagri G

Michaelides Michel, Besirli Cagri G, Yang Yesa, DE Guimaraes Thales A C, Wong Sui Chien, Huckfeldt Rachel M et al.

This gene therapy for XLRP-RPGR was safe, well-tolerated, and improved retinal sensitivity and functional vision, supporting further study.

Dolezal Kara A, Jacobson Adam, Besirli Cagri G, Elner Victor, Bohnsack Brenda L

Deng Callie, Zhao Peter Y, Branham Kari, Schlegel Dana, Fahim Abigail T, Jayasundera Thiran K et al.

Real-world data on voretigene neparvovec for pediatric RPE65-LCA shows significant, sustained visual function improvements, confirming its safety and efficacy for clinical use.

Jacobson Adam, Besirli Cagri G, Bohnsack Brenda L

Baerveldt implants for pediatric glaucoma show good initial success (84% at 1 year), but long-term success declines significantly (32% at 8 years), often requiring multiple surgeries for IOP control.

Miller Jason M L, Chang Emily, Besirli Cagri G, Johnson Mark W, Demirci Hakan

This study found a novel OCT sign—inner retinal thickening/lamination loss with preserved outer retina—helps differentiate leukemic papillopathy from uveitis, even with normal CSF/MRI, guiding earlier diagnosis.

Dolezal Kara A, Besirli Cagri G, Mian Shahzad I, Sugar Alan, Moroi Sayoko E, Bohnsack Brenda L

This study found Peters anomaly patients have poor long-term corneal transplant survival and high rates of complex, multi-surgery glaucoma, often requiring drainage devices or laser.